Policy changes Backwork has recorded, newest first. The most recent change on record is from October 11, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
82,244 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Axicabtagene Ciloleucel (Yescarta) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Axatilimab-csfr (Niktimvo) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Avelumab (Bavencio) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Avalglucosidase Alfa-ngpt (Nexviazyme) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Avacincaptad Pegol (Izervay) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Atezolizumab and Hyaluronidase-tqjs (Tecentria Hybreza) | Metadata changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Atezolizumab (Tecentriq) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Atezolizumab (Tecentriq) | Metadata changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Calaspargase Pegol-mknl (Asparlas) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Asparaginase Erwinia chrysanthemi (recombinant)-rywn (Rylaze) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | End Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema | Metadata changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Nelarabine (Arranon) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Darbepoetin Alfa (Aranesp) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Motixafortide (Aphexda) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Nogapendekin Alfa-Inbakicept-pmln (Anktiva) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Total Ankle Replacement | Metadata changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Anifrolumab-fnia (Saphnelo) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Anifrolumab-fnia (Saphnelo) | Metadata changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Amivantamab and Hyaluronidase-lpuj (Rybrevant Faspro) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Amivantamab-vmjw (Rybrevant) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Alpha-1 Proteinase Inhibitor (Aralast NP, Glassia, Prolastin-C, Zemaira) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Allogeneic Regulatory T Cell Immunotherapy with HSPC and T cells-vldq (Tregzi) | New policy |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Alglucosidase Alfa (Lumizyme) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Alemtuzumab (Lemtrada) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Laronidase (Aldurazyme) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Laronidase (Aldurazyme) | Metadata changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Agalsidase Beta(Fabrazyme) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Aflibercept Products (Eylea; EyleaHD, Ahzantive [aflibercept-mrbb], Enzeevu [Aflibercept-abzv], Eydenzelt [Aflibercept-boav], Opuviz [Aflibercept-yszy], Pavblu [Aflibercept-ayyh], and Yesafili [Aflibercept-jbvf]) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Afamitresgene Autoleucel (Tecelra) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Nadofaragene firadenovec-vncg (Adstiladrin) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Ado-Trastuzumab Emtansine (Kadcyla) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Brentuximab Vedotin (Adcetris) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | ADAMTS13, recombinant-krhn (Adzynma) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Crizanlizumab-tmca(Adakveo) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Corticotropin-ACTH: [HP Acthar Gel (repository corticotropin injection), Cortrophin Gel | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Tocilizumab (Actemra); Tocilizumab-anoh (Avtozma); Tocilizumab-bavi (Tofidence); Tocilizumab-aazg (Tyenne) | Metadata changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Rhinomanometry and Acoustic Rhinometry | Metadata changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Absorbable Nasal Implant for the Treatment of Nasal Valve Collapse | Metadata changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Paclitaxel (Albumin-Bound) (Abraxane; Paclitaxel Albumin-Bound) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | AbobotulinumtoxinA (Dysport) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Idecabtagene Vicleucel (Abecma) | Codes changed |
| Sep 29, 2026 | BlueCross BlueShield of Tennessee | Abatacept (Orencia) | Codes changed |
| Aug 22, 2026 | Carelon Medical Benefits Management | Uterine Cancer | Codes changed |
| Aug 22, 2026 | Carelon Medical Benefits Management | Testicular Cancer | Codes changed |
| Aug 22, 2026 | Carelon Medical Benefits Management | Myeloma | Codes changed |
| Aug 22, 2026 | Carelon Medical Benefits Management | Lymphoma (Mantle Cell) | Codes changed |
| Aug 22, 2026 | Carelon Medical Benefits Management | Lymphoma (Hodgkin) | Codes changed |
| Aug 22, 2026 | Carelon Medical Benefits Management | Lymphoma (Follicular & MZL) | Codes changed |
| Aug 22, 2026 | Carelon Medical Benefits Management | Lymphoma (DLBCL) | Codes changed |
| Aug 22, 2026 | Carelon Medical Benefits Management | Lymphoma (CLL, SLL) | Codes changed |